NEW YORK (GenomeWeb) – Qiagen and CareDx announced today that they have signed a deal to combine a Qiagen DNA analysis platform with CareDx's HLA typing kits and interpretation software, and market the combined product to transplant labs.

The firms will put together Qiagen's QIAxcel Advanced automated capillary electrophoresis system and CareDx's Olerup SSP kits and Score software as an additional option for HLA typing processing and data entry for transplant labs.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.